Epigenetische Kontrolle der Remyelinisierung bei Multipler Sklerose

Epigenetic control of remyelinisation in multiple sclerosis

by Anna Theresia Herget
Doctoral thesis
Date of Examination:2012-06-27
Date of issue:2012-06-15
Advisor:Prof. Dr. Christine Stadelmann-Nessler
Referee:Prof. Dr. Christine Stadelmann-Nessler
Referee:Prof. Dr. Bernhard Reuss
Persistent Address: http://dx.doi.org/10.53846/goediss-1550

 

 

Files in this item

Name:herget.pdf
Size:1.57Mb
Format:PDF

The following license files are associated with this item:

Abstract

English

A great variability of remyelinisation is frequently found in demyelinated plaques of patients with multiple sclerosis (MS). Regarding this variability recent studies have found a correlation between the Histone deacetylase 1 (HDAC1)-expression and the level of remyelinisation in mice. In this study we concentrated on the question whether this coherence also could be seen in patients with MS. Beforehand, we developed a classification for stages of remyelinating lesions by means of differential expression of various myelin proteins in oligodendrocytes. It showed that 2
Keywords: multiple sclerosis; HDAC1; remyelinisation; stages of remyelinisation; NogoA; CNP; MOG; MAG; MBP
Schlagwörter: Multiple Sklerose; HDAC1; Remyelinisierung; Remyelinisierungsstadien; NogoA; CNP; MOG; MAG; MBP
 
Statistik